18 transactions on file, per SEC Form 4 filings.
Gaffin David Joseph
EVP, CLO, Alkermes, Inc. · 2026-09-03
Sold
$98K
Hopkinson Craig C.
EVP R&D, Chief Medical Officer · 2026-09-01
Option exercise
$123K
Hopkinson Craig C.
EVP R&D, Chief Medical Officer · 2026-09-01
Sold
$423K
Nichols Christian Todd
SVP, Chief Commercial Officer · 2026-08-17
Sold
$340K
Nichols Christian Todd
SVP, Chief Commercial Officer · 2026-08-17
Sold
$33K
Jackson Blair Curtis
President & CEO, Alkermes plc · 2026-08-05
Award
$6.2M
Jackson Blair Curtis
President & CEO, Alkermes plc · 2026-08-05
Award
$4.6M
snyderman nancy lynn MD
director · 2026-08-03
Option exercise
$772K
snyderman nancy lynn MD
director · 2026-08-03
Option exercise
$1.3M
snyderman nancy lynn MD
director · 2026-08-03
Sold
$2.2M
Hopkinson Craig C.
EVP R&D, Chief Medical Officer · 2026-08-03
Option exercise
$120K
Hopkinson Craig C.
EVP R&D, Chief Medical Officer · 2026-08-03
Option exercise
$2K
Hopkinson Craig C.
EVP R&D, Chief Medical Officer · 2026-08-03
Sold
$437K
Gaffin David Joseph
EVP, CLO, Alkermes, Inc. · 2026-08-03
Sold
$99K
Gaffin David Joseph
EVP, CLO, Alkermes, Inc. · 2026-07-06
Sold
$110K
Hopkinson Craig C.
EVP R&D, Chief Medical Officer · 2026-07-01
Option exercise
$97K
Hopkinson Craig C.
EVP R&D, Chief Medical Officer · 2026-07-01
Sold
$427K
Hopkinson Craig C.
EVP R&D, Chief Medical Officer · 2026-07-01
Sold
$36K
Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.
Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.
Analyze ALKS